Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy
Por:
Ernst B.J., García-Aguirre G., Oliver S.C.N., Olson J.L., Mandava N., Quiroz-Mercado H.
Publicada:
1 ene 2012
Categoría:
Ophthalmology
Resumen:
[No abstract available]
Filiaciones:
Ernst B.J.:
Denver Health Medical Center, University of Colorado, 777 Bannock St., Denver, CO 80204, United States
García-Aguirre G.:
Retina Department, Asociación Para Evitar La Ceguera En México, Mexico City, Mexico
Oliver S.C.N.:
University of Colorado, Rocky Mountain Lions Eye Institute, Denver, CO, United States
Olson J.L.:
University of Colorado, Rocky Mountain Lions Eye Institute, Denver, CO, United States
Mandava N.:
University of Colorado, Rocky Mountain Lions Eye Institute, Denver, CO, United States
Quiroz-Mercado H.:
Denver Health Medical Center, University of Colorado, 777 Bannock St., Denver, CO 80204, United States
|